| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |